Wuxi Biologics Cayman (WXIBF, $1.46) was a top loser over the last three months, falling -3 to $1.46 per share. A.I.dvisor analyzed 894 stocks in the Biotechnology Industry for the 3-month period ending May 28, 2024, and found that of them (3) exhibited an Uptrend while of them (6) demonstrated a Downtrend.